The influence of symptoms and device detected atrial tachyarrhythmias on medical management: Insights from A-HIRATE

PACE - Pacing and Clinical Electrophysiology

Volumn 30, Issue 7, 2007, Pages 850-857

  Ghali, Jalal K ^a,d   Orlov, Michael V ^b,e   Araghi Niknam, Mohsen ^c   Sherfesee, Lou ^c   Hettrick, Douglas A ^c  

^a WAYNE STATE UNIVERSITY   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

^c MEDTRONIC   (United States)

^d DETROIT RECEIVING HOSPITAL   (United States)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atrial fibrillation; Atrial high rate episodes; Atrial tachyarrhythmias; Devices

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; WARFARIN;

AGED; ANGINA PECTORIS; ANTICOAGULANT THERAPY; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DRUG USE; DYSPNEA; EXERCISE TOLERANCE; FATIGUE; FEMALE; HEART ATRIUM PACING; HEART PALPITATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PROBABILITY; SINUS NODE DYSFUNCTION; SUPRAVENTRICULAR TACHYCARDIA; SYMPTOM; SYNCOPE; THORAX PAIN; TREATMENT INDICATION; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANTI-ARRHYTHMIA AGENTS; ANTICOAGULANTS; FEMALE; HEART ATRIA; HEART RATE; HUMANS; MALE; MULTICENTER STUDIES; PACEMAKER, ARTIFICIAL; PROSPECTIVE STUDIES; TACHYCARDIA;

EID: 34250781226     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2007.00772.x     Document Type: Article

References (19)

1. Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation); North American Society of Pacing and Electrophysiology: ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: Executive summary practice guidelines and policy conferences. (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. Circulation 2001 104 : 2118 2150.
2. Limousin M, Geroux L, Nitzsche R, Cazeau S, Pioger G, Victor J, Poty H, et al. Value of automatic processing and reliability of stored data in an implanted pacemaker: Initial results in 59 patients. Pacing Clin Electrophysiology 1997 20 : 2893 2898.
3. Defaye P, Dournaux F, Mouton E. Prevalence of supraventricular arrhythmias from the automated analysis of data stored in the DDD pacemakers of 617 patients: The AIDA study. The AIDA Multicenter Study Group. Automatic Interpretation for Diagnosis Assistance. Pacing Clin Electrophysiol 1998 21 : 250 255.
4. Gillis AM, Morck M. Atrial Fibrillation after DDDR pacemaker implantation. Journal of Cardiovasc Electrophysiology 2002 13 : 542 547.
5. Fauchier L, Briand F, Soto FX, Quennelle F, Levy J, Darmon JP, Lellouche D, et al. Management of atrial tachyarrhythmias: Benefits of pacemaker diagnostics. Pacing Clin Electrophysiol 2003 26 : 233 238.
6. Marshall AJ, Nash A, Owen PA, Todd D, Jones D. Pacemaker diagnostics to determine treatment and outcome in sick sinus syndrome with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 2004 27 : 1130 1135.
7. Schuchert A, Lepage S, Ostrander JJ, Bos RJ, Gwechenberger M, Nicholls A, Ringwald G. Automatic analysis of pacemaker diagnostic data in the identification of atrial tachyarrhythmias in patients with no prior history of them. Europace 2005 7 : 242 247.
8. Israel CW, Gronefeld G, Ehrlich JR, Li YG, Hohnloser SH. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: Implications for optimal patient care. J Am Coll Cardiol 2004 43 : 47 52.
9. Purerfellner H, Gillis AM, Holbrook R, Hettrick DA. Accuracy of atrial tachyarrhythmia detection in implantable devices with arrhythmia therapies. Pacing Clin Electrophysiol 2004 27 : 983 992.
10. Glotzer TV, Hellkamp AS, Zimmerman J, Sweeney MO, Yee R, Marinchak R, Cook J, et al. MOST Investigators: Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke. Report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). Circulation 2003 107 : 1614 1619.
11. Capucci A, Santini M, Padeletti L, Gulizia M, Botto G, Boriani G, Ricci R, et al. Italian AT500 Registry Investigators: Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. JACC 2005 46 : 1913 1920.
12. Orlov MV, Ghali JK, Araghi-Niknam M, Sherfesee L, Sahr D, Hettrick DA. Asymptomatic atrial fibrillation in pacemaker recipients: Incidence, progression and determinants based on the Atrial High Rate Trial. Pacing Clin Electrophysiol (in press).
13. Diggle PJ, Liang KY, Zeger SL. Analysis of Longitudinal Data. Oxford Science Publications. 1994. pp. 151 162.
14. Swedberg K, Olsson LG, Charlesworth A, Cleland J, Hanrath P, Komajda M, Metra M, et al. Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long term treatment with β-blockers: Results from COMET. Eur Heart J 2005 13 : 1303 1308.
15. Van Veldhuisen DJ, Aass H, El Allaf D, Dunselman PH, Gullestad L, Halinen M, Kjekshus J, et al. Group. Presence and development of atrial fibrillation in chronic heart failure. Experience from the MERIT-HF Study. Eur J Heart Fail 2006 5 : 539 546.
16. Kuhlkamp V, Schirdewan A, Stangl K, Homberg M, Ploch M, Beck OA. Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: A randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 2000 36 : 139 146.
17. Page RL, Wilkinson WE, Clair WK, McCarthy EA, Pritchett EL. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 1994 89 : 224 227.
18. Levy S, Maarek M, Coumel P, Guize L, Lekieffre J, Medvedowsky JL, Sebaoun A. Characterization of different subsets of atrial fibrillation in general practice in France. The ALFA study. The College of French Cardiologists. Circulation 1999 99 : 3028 2035.
19. Flaker GC, Belew K, Beckman K, Vidaillet H, Kron J, Safford R, Mickel M, et al. AFFIRM Investigators: Asymptomatic atrial fibrillation: Demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study. Am Heart J 2005 149 : 657 663.